Fortis Healthcare Limited — Q3 FY25
Fortis Healthcare delivered a strong Q3 FY25 with consolidated revenue of INR 1,928 crore (+14.8% YoY) and EBITDA of INR 375 crore (+32% YoY), driven by the hospital business wh...
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q2 FY25
Hospital EBITDA margin expansion of 200 bps for FY25
Management reaffirmed guidance of 200 bps margin expansion for the hospital business for the full year, factoring in initial losses from Manesar.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1